Bausch Health Companies Inc. 3.25% 01/27/38 EMTN

Bausch Health Companies Inc. 3.25% 01/27/38 EMTN is a long-term euro medium-term note issued by Bausch Health Companies Inc., a specialty pharmaceutical company focused on developing, manufacturing, and marketing pharmaceutical products across segments including U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics in Europe, and Branded Generics in Latin America. This corporate bond features a low fixed coupon rate of 3.25%, paid semi-annually, with a distant maturity date of January 27, 2038, making it a significant long-duration instrument in the issuer's debt profile. As part of Bausch Health's extensive bond portfolio, which includes various senior unsecured, secured, and guaranteed notes with maturities ranging from 2027 to 2032 and coupons from 4.875% to 14%, this EMTN supports the company's financing needs amid a complex capital structure involving substantial debt refinancing efforts and asset-backed facilities. Traded internationally, it reflects the company's role in the high-yield pharmaceutical sector, where investors seek fixed-income exposure to healthcare innovation while navigating the issuer's historical challenges and ongoing maturity management.